FindTrial
Sign In

Evaluation effect of COMPASS-CAT and Khorana Risk Assessment Model to predict the risk of venous thromboembolism in patients with daytime tumor in China

Evaluation effect of COMPASS-CAT and Khorana Risk Assessment Model to predict the risk of venous thromboembolism in patients with daytime tumor in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065993
Enrollment
Unknown
Registered
2022-11-21
Start date
2022-03-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thromboembolism

Interventions

Gold Standard:Blood vessel B ultrasound, chest CT
Index test:COMPASS-CAT and khorana thrombosis risk assessment model

Sponsors

Medical Oncology of the First Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to the day ward with tumors confirmed and in the active stage; 2. Aged >= 18 years; 3. Survival >= 6 months; 4. Hospital stay <= 24 hours.

Exclusion criteria

Exclusion criteria: 1. VTE had occurred before the diagnosis of tumor; 2. Patients suffering from serious diseases of the blood system; 3. Incomplete information affects the judge.

Design outcomes

Primary

MeasureTime frame
ROC, Receiver Operating Characteristic Curve;Area under the curve, AUC;Sensitivity to prediction;Specificity of prediction;Accuracy of prediction;—

Countries

China

Contacts

Public ContactJinqiong Wu

The First Affiliated Hospital of Zhejiang University School of Medicine

303832483@qq.com+86 13567138952

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026